Gefitero 250mg Tablet

Gefitero 250mg Tablet contains Gefitinib, a selective tyrosine kinase inhibitor designed to target the epidermal growth factor receptor (EGFR). This medication is primarily indicated for the treatment of non-small cell lung cancer (NSCLC). By blocking the activity of EGFR, Gefitinib helps to disrupt cancer cell growth and proliferation, making it a crucial part of advanced cancer therapy.

Key Features:

• Contains Gefitinib, a powerful targeted therapy medication
• Indicated for the treatment of non-small cell lung cancer (NSCLC)
• Inhibits EGFR signaling to slow the progression of cancer cells
• Available in a convenient oral tablet form
• Often used as part of a comprehensive cancer treatment strategy